Upstream Medical Technologies Ltd - Product Pipeline Analysis, 2021 Update

Summary

Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for diagnoses of unstable angina, CVD, ACS, and others. It provides pipe line product such as Ghr-sp-Pne diagnoses heart failure in the presence of pneumonia; and EPO-sp for detection of kidney failure. It offers products to identify comorbid disease associated with kidney failure, metabolic disease, sepsis and atrial fibrillation, among others. The company develops biomarker-based testing for diagnoses of heart disease and associated clinical complications. UMT is headquartered in Christchurch, New Zealand.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Upstream Medical Technologies Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Upstream Medical Technologies Ltd Company Overview
Upstream Medical Technologies Ltd Company Snapshot
Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
Upstream Medical Technologies Ltd Pipeline Analysis Overview
Upstream Medical Technologies Ltd - Key Facts
Upstream Medical Technologies Ltd - Major Products and Services
Upstream Medical Technologies Ltd Pipeline Products by Development Stage
Upstream Medical Technologies Ltd Pipeline Products Overview
CNP-sp Test - Heart Disease
CNP-sp Test - Heart Disease Product Overview
CRP-sp Assay - Heart Failure
CRP-sp Assay - Heart Failure Product Overview
EPO-sp Test
EPO-sp Test Product Overview
GH Assay - Heart Failure
GH Assay - Heart Failure Product Overview
Ghr-sp Test - Heart Disease
Ghr-sp Test - Heart Disease Product Overview
Ghr-sp-Pne Test - Heart Failure
Ghr-sp-Pne Test - Heart Failure Product Overview
IGFs Assay - Heart Failure
IGFs Assay - Heart Failure Product Overview
INS-sp Test - Heart failure
INS-sp Test - Heart failure Product Overview
KIM-1sp Assay - Heart Failure
KIM-1sp Assay - Heart Failure Product Overview
NGAL-sp Test - Heart Failure
NGAL-sp Test - Heart Failure Product Overview
PSA-sp Assay - Heart Failure
PSA-sp Assay - Heart Failure Product Overview
TnTuORF Test - Acute Coronary Syndrome
TnTuORF Test - Acute Coronary Syndrome Product Overview
TSH Assay - Heart Failure
TSH Assay - Heart Failure Product Overview
UARatio Test - Angina
UARatio Test - Angina Product Overview
Upstream Medical Technologies Ltd - Key Competitors
Upstream Medical Technologies Ltd - Key Employees
Upstream Medical Technologies Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Upstream Medical Technologies Ltd, Recent Developments
May 15, 2017: Upstream Medical Technologies Provides Update on UARatio Test - Angina
Jul 08, 2016: Upstream Medical Technologies: Dr Jim Januzzi accepts appointment to Scientific Advisory Board
Jun 02, 2016: Professor Mark Richards accepts appointment to Scientific Advisory Board of Upstream Medical Technologies
Oct 28, 2015: Breakthrough Medical Research Company Formed
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

List of Tables
Upstream Medical Technologies Ltd Pipeline Products and Ongoing Clinical Trials Overview
Upstream Medical Technologies Ltd Pipeline Products by Equipment Type
Upstream Medical Technologies Ltd Pipeline Products by Indication
Upstream Medical Technologies Ltd, Key Facts
Upstream Medical Technologies Ltd, Major Products and Services
Upstream Medical Technologies Ltd Number of Pipeline Products by Development Stage
Upstream Medical Technologies Ltd Pipeline Products Summary by Development Stage
CNP-sp Test - Heart Disease - Product Status
CNP-sp Test - Heart Disease - Product Description
CRP-sp Assay - Heart Failure - Product Status
CRP-sp Assay - Heart Failure - Product Description
EPO-sp Test - Product Status
EPO-sp Test - Product Description
GH Assay - Heart Failure - Product Status
GH Assay - Heart Failure - Product Description
Ghr-sp Test - Heart Disease - Product Status
Ghr-sp Test - Heart Disease - Product Description
Ghr-sp-Pne Test - Heart Failure - Product Status
Ghr-sp-Pne Test - Heart Failure - Product Description
IGFs Assay - Heart Failure - Product Status
IGFs Assay - Heart Failure - Product Description
INS-sp Test - Heart failure - Product Status
INS-sp Test - Heart failure - Product Description
KIM-1sp Assay - Heart Failure - Product Status
KIM-1sp Assay - Heart Failure - Product Description
NGAL-sp Test - Heart Failure - Product Status
NGAL-sp Test - Heart Failure - Product Description
PSA-sp Assay - Heart Failure - Product Status
PSA-sp Assay - Heart Failure - Product Description
TnTuORF Test - Acute Coronary Syndrome - Product Status
TnTuORF Test - Acute Coronary Syndrome - Product Description
TSH Assay - Heart Failure - Product Status
TSH Assay - Heart Failure - Product Description
UARatio Test - Angina - Product Status
UARatio Test - Angina - Product Description
Upstream Medical Technologies Ltd, Key Employees
Glossary

List Of Figures

List of Figures
Upstream Medical Technologies Ltd Pipeline Products by Equipment Type
Upstream Medical Technologies Ltd Pipeline Products by Development Stage

Upstream Medical Technologies Ltd - Product Pipeline Analysis, 2021 Update

Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for

USD 750 View Report

Upstream Medical Technologies Ltd - Product Pipeline Analysis, 2021 Update

Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for

USD 750 View Report

Upstream Medical Technologies Ltd - Product Pipeline Analysis, 2021 Update

Upstream Medical Technologies Ltd (UMT) is a biomarker based testing developer that markets novel biomarkers for cardiac diagnosis. The company offers patented pipeline of products such as BNP-sp, used for

USD 750 View Report

PixCell Medical Technologies Ltd - Product Pipeline Analysis, 2020 Update

PixCell Medical Technologies Ltd (PixCell) is a medical device company that develops, produces and markets portable medical diagnostic products for point of care testing. The companys product comprises hemoscreen, a

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available